Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy

As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not to an equal degree, the biotechnology, pharmaceutical, and life science industries have not been excluded from employment cuts. In January, Verily, the healthcare and life sciences subsidiary of Alphabet, Inc., announced a restructuring that would cut about 15% of its workforce. Likewise, several other biotech giants, including Thermo Fisher…
By: Knobbe Martens
Previous Story

French decree regarding the “direct access”: a half-hearted step forward for pharmaceutical innovations

Next Story

The Trend Continues: Increased Regulatory Focus on Privacy & Cybersecurity for Private Funds